Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Doyle, J. Cheong, R. Ehrenkranz, H. Halliday (2017)
Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.The Cochrane database of systematic reviews, 10
N. Parikh (2021)
The Swinging Pendulum of Postnatal Corticosteroid Use.JAMA pediatrics
V. Ramaswamy, T. Bandyopadhyay, Debasish Nanda, Prathik Bandiya, J. Ahmed, Anip Garg, C. Roehr, S. Nangia (2021)
Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.JAMA pediatrics
D. Weisz, E. Yoon, M. Dunn, J. Emberley, A. Mukerji, Brooke Read, P. Shah (2020)
Duration of and trends in respiratory support among extremely preterm infantsArchives of Disease in Childhood, 106
M. Laughon, E. Allred, C. Bose, T. O'Shea, L. Marter, R. Ehrenkranz, A. Leviton (2009)
Patterns of Respiratory Disease During the First 2 Postnatal Weeks in Extremely Premature InfantsPediatrics, 123
Letters over different points of time. J Pediatr Hematol Oncol. 2018;40(2):e83-e90. the editorialist still recommends using low cumulative doses doi:10.1097/MPH.0000000000001060 (less than 2 mg/kg). 4. Brown K, Farmer C, Farhadian B, Hernandez J, Thienemann M, Frankovich J. Preventing BPD is crucial, given its respiratory and non- Pediatric acute-onset neuropsychiatric syndrome response to oral respiratory outcomes, and the use of corticosteroids in in- corticosteroid bursts: an observational study of patients in an academic fants at risk of BPD being treated with noninvasive ventila- community-based PANS clinic. J Child Adolesc Psychopharmacol. 2017;27(7): 629-639. doi:10.1089/cap.2016.0139 tion is, to our best knowledge, an as-yet unexplored field that 5. Leonard A, Godiwala N, Herrera N, McCarter R, Sharron M, Meier ER. Early deserves a closer look. It is likely that neonatologists will be initiation of inhaled corticosteroids does not decrease acute chest syndrome using this practice in the coming years. morbidity in pediatric patients with sickle cell disease. Blood Cells Mol Dis. 2018; 71:55-62. doi:10.1016/j.bcmd.2018.03.001 Luca Bonadies, MD, PhD 6. Kimura Y, Grevich S, Beukelman T, et al; CARRA Registry Investigators. Pilot Daniel Nardo, MD study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic juvenile idiopathic arthritis consensus treatment plans. Eugenio Baraldi,
JAMA Pediatrics – American Medical Association
Published: Oct 6, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.